Pulmonx Total Liabilities 2019-2024 | LUNG

Pulmonx total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Pulmonx Annual Total Liabilities
(Millions of US $)
2024 $77
2023 $59
2022 $40
2021 $42
2020 $38
2019 $36
2018 $42
Pulmonx Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $77
2024-09-30 $73
2024-06-30 $71
2024-03-31 $54
2023-12-31 $59
2023-09-30 $59
2023-06-30 $59
2023-03-31 $57
2022-12-31 $40
2022-09-30 $39
2022-06-30 $41
2022-03-31 $41
2021-12-31 $42
2021-09-30 $44
2021-06-30 $39
2021-03-31 $39
2020-12-31 $38
2020-09-30 $278
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
2018-12-31 $42
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.138B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.877B 52.32
Hims & Hers Health (HIMS) United States $10.991B 115.05
Tempus AI (TEM) United States $8.988B 0.00
Inspire Medical Systems (INSP) United States $4.774B 74.60
IRhythm Technologies (IRTC) United States $4.316B 0.00
Privia Health (PRVA) United States $2.756B 206.54
Enovis (ENOV) United States $1.947B 12.05
Schrodinger (SDGR) United States $1.721B 0.00
Clover Health Investments (CLOV) United States $1.712B 0.00
Phreesia (PHR) United States $1.426B 0.00
Omnicell (OMCL) United States $1.202B 21.21
Azenta (AZTA) United States $1.162B 54.08
10x Genomics (TXG) United States $0.991B 0.00
Fulgent Genetics (FLGT) United States $0.573B 0.00
Talkspace (TALK) United States $0.530B 157.25
Butterfly Network (BFLY) United States $0.527B 0.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.381B 0.00
Claritev (CTEV) United States $0.329B 0.00
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.218B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
American Well (AMWL) United States $0.106B 0.00
Retrieve Medical Holdings (RMHI) United States $0.095B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
CareCloud (CCLD) United States $0.091B 3.45
MDxHealth SA (MDXH) Belgium $0.080B 0.00
111 (YI) China $0.069B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.062B 0.00
Outset Medical (OM) United States $0.041B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00